It is of note that adiponectin levels in metabolically healthy individuals with obesity (MHO) are higher than those with impaired metabolic health93; it is the latter group that is predisposed to increased risk of pneumonia and worse outcome in COVID‐19.97 This evidence concerns the gene ADIPOQ and obesity disorder.